Literature DB >> 1415958

Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.

O P Sangueza1, S Yadav, C R White, R M Braziel.   

Abstract

Cutaneous B-cell lymphomas are rare neoplasms that can present as lesions involving solely the skin or develop in association with a systemic lymphoma. Histologically they are often difficult to differentiate from pseudolymphomas, and the use of immunohistochemistry may be necessary to correctly classify them. We report a study of multiple skin lesions in a patient who initially presented with multiple pseudolymphomas, apparently associated with an immune response to the dye of his tattoos. Over a period of 4 years his skin lesions evolved from histologically benign and immunologically polyclonal pseudolymphomas to a histologically malignant and immunologically monoclonal B-cell large cell lymphoma. Genotypic analysis with a probe for the heavy-chain immunoglobulin gene demonstrated the presence of clonal B-cell populations in all of the pseudolymphoma biopsy samples as well as in the subsequent lymphoma tissue samples, with a pattern of clonal bands suggestive of evolution of the B-cell clones. These findings suggest that the development of B-cell lymphoma in this patient was related to a persistent abnormal immune response to the chronic antigenic stimulus of the dye of the tattoo. The presence of clonal B-cell populations in pseudolymphoma by Southern blot analysis may be useful in predicting those patients who will subsequently develop overt lymphoma.

Entities:  

Mesh:

Year:  1992        PMID: 1415958     DOI: 10.1097/00000372-199210000-00006

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

Review 1.  Lasers for tattoo removal: a review.

Authors:  Sonal Choudhary; Mohamed L Elsaie; Angel Leiva; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2010-06-12       Impact factor: 3.161

Review 2.  [Tattooing agents and adverse reactions].

Authors:  G Wagner; V Meyer; M M Sachse
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

3.  [Cutaneous B-cell lymphoma. Classification and diagnostics].

Authors:  E Geissinger; P Adam; H K Müller-Hermelink; T Rüdiger
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

4.  Duodenal pseudolymphoma: a case report and review of literature.

Authors:  Yong-Heng Huang; Tian-Zhu Long; Zhi-Yu Xiao; Hua Ye; Yun-Le Wan; Jie Wang
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

5.  Pseudolymphoma tattoo-induced.

Authors:  Giorgio Pasolini; Patrizia Ghidini; Mariachiara Arisi; Alessandra Pedretti; Marco Ungari; Piergiacomo Calzavara Pinton
Journal:  Dermatol Reports       Date:  2011-11-29

6.  Tattoo-associated skin reaction: the importance of an early diagnosis and proper treatment.

Authors:  Andrea Bassi; Piero Campolmi; Giovanni Cannarozzo; Rossana Conti; Nicola Bruscino; Massimo Gola; Stefano Ermini; Daniela Massi; Silvia Moretti
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

7.  Pseudolymphomatous Reaction to Red Tattoo Pigment.

Authors:  Ieva Saulite; Agnes Pekar-Lukacs; Katrin Kerl; Antonio Cozzio; Wolfram Hoetzenecker; Emmanuella Guenova
Journal:  Case Rep Dermatol       Date:  2018-06-14

8.  A Random Walk-Based Method to Identify Candidate Genes Associated With Lymphoma.

Authors:  Minjie Sheng; Haiying Cai; Qin Yang; Jing Li; Jian Zhang; Lihua Liu
Journal:  Front Genet       Date:  2021-11-25       Impact factor: 4.599

9.  Squamous Cell Carcinoma and Tattoo: A Man With a Tattoo-Associated Squamous Cell Carcinoma and Review of Benign Tumors, Lymphoid Conditions, and Malignant Neoplasms Occurring Within a Tattoo.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2022-01-10

10.  Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report.

Authors:  Akinori Sekizawa; Kenichi Hashimoto; Shinichi Kobayashi; Sawako Kozono; Takahiro Kobayashi; Yusuke Kawamura; Motohiro Kimata; Naoya Fujita; Yosuke Ono; Yasuhiro Obuchi; Yuji Tanaka
Journal:  Front Med (Lausanne)       Date:  2022-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.